Colorectal cancer exhibits high heterogeneity,26 with molecularly defined subgroups who differ in their outcomes.27,28,29 In this study, we discovered that the advantages of the simultaneous resection strategy was restricted to patients with KRAS wild-type tumors. The gene discussed is KRAS; the disease is colorectal cancer.